Target intelligence / Profile preview

Mycobacterial membrane and energy production machinery

Molecular classification
Enzyme, Transporter, Protein complex
01

Overview

The mycobacterial membrane and energy production machinery refers to the integrated network of proteins and pathways responsible for ATP synthesis and the maintenance of the unique mycobacterial cell envelope. This system includes the oxidative phosphorylation (OXPHOS) pathway, featuring key enzymes such as ATP synthase and the cytochrome bc1-aa3 complex, as well as transporters like MmpL3 that facilitate the assembly of the mycolic acid layer (Cook et al., 2017; Tahlan et al., 2012). These components are essential for the survival of Mycobacterium tuberculosis, particularly in the nutrient-poor and hypoxic environments of the host granuloma where the bacteria may enter a non-replicating persistent state (Andries et al., 2005). Therapeutic targeting of this machinery has emerged as a cornerstone of modern tuberculosis treatment, as it bypasses traditional resistance mechanisms associated with DNA replication or protein synthesis (Pethe et al., 2013). Drugs like Bedaquiline and Telacebec (Q203) specifically disrupt energy production, leading to rapid bactericidal activity and the potential for shortened treatment regimens (Diacon et al., 2014). However, targeting these pathways requires careful management of safety concerns, such as cardiotoxicity and complex drug-drug interactions (World Health Organization, 2020).

Other names
Mycobacterial oxidative phosphorylation systemMycobacterial respiratory chainMycobacterial cell envelope synthesis machineryMtb energy metabolism
02

Mechanism of action

Inhibition of ATP synthase, inhibition of the cytochrome bc1-aa3 complex (QcrB), and inhibition of the MmpL3 transporter involved in cell wall assembly.

03

Biological functions

Energy metabolismCell wall synthesisRespirationIon homeostasis
04

Disease associations

Infection
05

Safety considerations

QT interval prolongationHepatotoxicityDrug-drug interactions (CYP3A4 induction/inhibition)Potential for cross-resistanceLong terminal half-life (Bedaquiline)
06

Interacting drugs

Bedaquiline

4 more in the full profile.

07

Biomarkers

Sputum culture conversion (SCC)Time to positivity (TTP) in liquid cultureEarly bactericidal activity (EBA)

Beyond the preview

Go deeper on Mycobacterial membrane and energy production machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterial membrane and energy production machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call